DYADIC INTERNATIONAL INC Money Market Funds, at Carrying Value
DYADIC INTERNATIONAL INC (DYAI) had Money Market Funds, at Carrying Value of $3.52 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2025-05-14
- 2025-03-31: Money Market Funds, at Carrying Value $3.52M.
- 2024-12-31: Money Market Funds, at Carrying Value $5.58M.
- 2024-09-30: Money Market Funds, at Carrying Value $4.83M.
- 2024-06-30: Money Market Funds, at Carrying Value $5.45M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2025-03-31 | $3.52M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.58M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $4.83M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.45M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $9.73M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.49M 10-K · filed 2025-03-26 |
| 2023-09-30 | $6.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.51M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.77M 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.08M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.95M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $11.33B 10-Q · filed 2022-05-12 |
| 2021-12-31 | $14.37M 10-K · filed 2023-03-29 |
| 2021-09-30 | $12.17M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $13.20M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $11.84M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $20.49M 10-K · filed 2022-03-29 |
| 2019-12-31 | $3.81M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |